Biological treatment for bullous pemphigoid

BACKGROUND: Bullous pemphigoid (BP) is the most common autoimmune subepidermal bullous disease. Topical or systemic corticosteroids are often used as the first-line treatment. However, long-term corticosteroid use may lead to significant side effects. Therefore, various adjuvant immunosuppressant th...

Descripción completa

Detalles Bibliográficos
Autores principales: Oren-Shabtai, Meital, Mimouni, Daniel, Nosrati, Adi, Atzmony, Lihi, Kaplan, Baruch, Barzilai, Aviv, Baum, Sharon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172582/
https://www.ncbi.nlm.nih.gov/pubmed/37180101
http://dx.doi.org/10.3389/fimmu.2023.1157250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172582/
https://www.ncbi.nlm.nih.gov/pubmed/37180101
http://dx.doi.org/10.3389/fimmu.2023.1157250

Ejemplares similares